241 related articles for article (PubMed ID: 20101222)
1. DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells.
Gandhi M; Dillon LW; Pramanik S; Nikiforov YE; Wang YH
Oncogene; 2010 Apr; 29(15):2272-80. PubMed ID: 20101222
[TBL] [Abstract][Full Text] [Related]
2. DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.
Lehman CE; Dillon LW; Nikiforov YE; Wang YH
Carcinogenesis; 2017 Mar; 38(3):293-301. PubMed ID: 28069693
[TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerases participate in fragility of the oncogene RET.
Dillon LW; Pierce LC; Lehman CE; Nikiforov YE; Wang YH
PLoS One; 2013; 8(9):e75741. PubMed ID: 24040417
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
[TBL] [Abstract][Full Text] [Related]
5. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
[TBL] [Abstract][Full Text] [Related]
6. [RET/PTC Gene Rearrangements in the Sporadic and Radiogenic Thyroid Tumors: Molecular Genetics, Radiobiology and Molecular Epidemiology].
Ushenkova LN; Koterov AN; Biryukov AP
Radiats Biol Radioecol; 2015; 55(3):229-49. PubMed ID: 26310016
[TBL] [Abstract][Full Text] [Related]
7. [Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data].
Koterov AN; Ushenkova LN; Biryukov AP
Radiats Biol Radioecol; 2016; 56(1):5-25. PubMed ID: 27245001
[TBL] [Abstract][Full Text] [Related]
8. Suitability of animal models for studying radiation-induced thyroid cancer in humans: evidence from nuclear architecture.
Gandhi M; Nikiforov YE
Thyroid; 2011 Dec; 21(12):1331-7. PubMed ID: 22136268
[TBL] [Abstract][Full Text] [Related]
9.
Khonrak T; Watcharadetwittaya S; Chamgramol Y; Intarawichian P; Deenonpoe R
Pathol Oncol Res; 2023; 29():1611138. PubMed ID: 37188126
[No Abstract] [Full Text] [Related]
10. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM
Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605
[TBL] [Abstract][Full Text] [Related]
11. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
[TBL] [Abstract][Full Text] [Related]
12. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
13. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
14. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
[TBL] [Abstract][Full Text] [Related]
15. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
[TBL] [Abstract][Full Text] [Related]
16. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
Vasil'ev EV; Rumiantsev PO; Saenko VA; Il'in AA; Poliakova EIu; Nemtsova MV; Zaletaev DV
Mol Biol (Mosk); 2004; 38(4):642-53. PubMed ID: 15456136
[TBL] [Abstract][Full Text] [Related]
17. Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts.
Imkamp F; von Wasielewski R; Musholt TJ; Musholt PB
J Surg Res; 2007 Dec; 143(2):350-63. PubMed ID: 17655865
[TBL] [Abstract][Full Text] [Related]
18. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.
Gandhi M; Evdokimova V; Nikiforov YE
Mol Cell Endocrinol; 2010 May; 321(1):36-43. PubMed ID: 19766698
[TBL] [Abstract][Full Text] [Related]
20. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
